OmerKucukMD

Oncology • Atlanta, GA

Professor of Hematology and Medical Oncology

Join to view full profile

Dr. Kucuk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kucuk's full profile

Already have an account?

Office
5665 Peachtree Dunwoody Rd
Atlanta, GA 30342
Phone+1 678-843-7001

Fax+1 404-851-7339

Summary

Dr. Omer Kucuk is an oncologist in Atlanta, GA and is affiliated with multiple hospitals in the area, including Emory University Hospital, Emory University Hospital Midtown, Grady Memorial Hospital, and Emory Saint Joseph's Hospital of Atlanta. He received his medical degree from Hacettepe University Faculty of Medicine and has been in practice 42 years. He specializes in genitourinary oncology and is experienced in prostate cancer, urinary bladder cancer, kidney cancer and testis cancer.

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1980 - 1981
Presence Saint Francis HospitalFellowship, Hematology and Medical Oncology, 1979 - 1980
Presence Saint Francis HospitalFellowship, Hematology, 1978 - 1979
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1975 - 1978
Hacettepe University FOMClass of 1975

Certifications & Licensure

HI State Medical License 1991 - 2026
GA State Medical License 2008 - 2025
MI State Medical License 1977 - 2024
IL State Medical License 1977 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2010-2014
Atlanta Magazine: Top Doctors Castle Connolly, 2010-2014
America's Top Doctors for Cancer Castle Connolly, 2009-2013
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth Start of enrollment: 1997 Dec 01
Terminated
Phase 2
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer Start of enrollment: 2000 Dec 18
Completed
Phase 3
Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia Start of enrollment: 2003 Jun 01
Completed
Phase 2
Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate Start of enrollment: 2001 Nov 01
Completed
Phase 2
Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer Start of enrollment: 2002 May 01
Completed
Phase 2
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor Start of enrollment: 2006 Oct 01
Completed
Phase 1, Phase 2
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
Active, not recruiting
Phase 2
CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2013 Sep 10
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.
Tony Z Zhuang, Subir Goyal, Katherine B Case, T Anders Olsen, Shalini Vemuru
Journal of Immunotherapy and Precision Oncology. 2025-02-01
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.
Benjamin D Hopkins, David C Qian, Karen M Xu, Ashley McCook-Veal, Jeffrey Switchenko
Clinical Genitourinary Cancer. 2025-02-01
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.
Ahmet Yildirim, Mengting Wei, Yuan Liu, Bassel Nazha, Jacqueline T Brown
Therapeutic Advances in Medical Oncology. 2025-01-01

Journal Articles

The Addition of Chemotherapy in the Definitive Management of High Risk Prostate Cancer
Bradley C Carthon, Mehmet A Bilen, Omer Kucuk, Urologic Oncology

Authored Content

Retraction Notice to: Sensitization of Squamous Cell Carcinoma to Cisplatin Induced Killing by Natural AgentsMarch 2018

Press Mentions

Angelina Jolie's Doctor Urges Women to UP Their Soya Intake, Devour More of One Type of Fruit and Ditch Anti-Bacterial Soap as She Shares Her Top 10 Tips to Prevent Breast CancerOctober 6th, 2017
Soy Products Are GOOD for Fighting Breast Cancer, Study Finds - After Confusing One-off Research Said the OppositeMarch 8th, 2017
Winship Expert Touts Soy Use in the Journal CancerMarch 6th, 2017
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member